Screener
Sarepta Therapeutics, Inc. SRPT Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Sarepta Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
FAQ
- What is Sarepta Therapeutics, Inc.'s asset turnover?
- Sarepta Therapeutics, Inc. (SRPT) reported asset turnover of 0.6× in Q2 2026.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s asset turnover?
- Over 4 years (2020 to 2025), Sarepta Therapeutics, Inc.'s asset turnover has grown at a 27.9% compound annual growth rate (CAGR), from 0.2× to 0.6×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Sarepta Therapeutics, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude